Mylan president Rajiv Malik has been named in an expanded federal lawsuit filed by attorneys general in nearly every state, that accuses Mylan and more than a dozen other drugmakers of conspiring to fix prices for generic drugs.
The amended complaint, which state officials are asking federal court for permission to file, also names Satish Mehta, CEO of the India-based drugmaker Emcure Pharmaceuticals, the parent company of Heritage Pharmaceuticals in New Jersey.
Mr. Malik and Mr. Mehta would be the first senior executives sued in the case.
“These conspiracies were part of a much broader, overarching industry code of conduct that enabled the [drugmakers] to divvy up the market for specific generic drugs in accordance with an established, agreed-upon understanding for assigning each competitor their share of the market,” said Connecticut Attorney General George Jepsen, who is leading the antitrust investigation, in a statement.
The original lawsuit, filed in December 2016 in Connecticut and then moved to Philadelphia in August, named Mylan, Heritage Pharmaceuticals and four other drugmakers, accusing them of conspiring to fix prices for two drugs. The new complaint expands the number of generic drug companies to 18 and the number of drugs at issue to 15.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU’s Incoming Competition Head Pushes for Policy Shift to Support ‘European Champions
Sep 19, 2024 by
CPI
Google Challenges $217 Million Legal Fee Demand in Privacy Case
Sep 19, 2024 by
CPI
EU Moves to Enforce Apple’s Compliance with New Market Rules
Sep 19, 2024 by
CPI
California Attorney General Bonta Stands Firm Against Albertsons-Kroger Merger
Sep 19, 2024 by
CPI
New FTC Report Highlights Privacy Risks in Social Media Data Use
Sep 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
Francisco Javier Núñez Melgoza
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
Julio Garcia
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
Alejandra Palacios Prieto
The Cost of Making COFECE Disappear
Sep 3, 2024 by
Mateo Fernández